Possible new target for treating one of cancer's deadliest tumors. Researchers have identified an enzyme that may be the weak link in glioblastoma, a brain cancer that is resistant to most treatments

DeSjardins, Annick

Duke Medicine Health News, 2013, Vol.19 (9), p.7-7

United States: Belvoir Media Group, LLC

Texto completo disponível